PQ401 (PQ-401) is a novel, potent and selective inhibitor of IGF-1R (insulin-like growth factor-1 receptor) with potential antineoplastic activity.

Linsitinib (formerly OSI-906; OSI 906) is a firs-in-class, ATP-competitive and orally bioavailable dual inhibitor of and insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF-1R) with potential antitumor activity.

NVP-ADW742 (also known as ADW-742; ADW 742; GSK552602A; GSK-552602A) is a novel, potent and selective IGF-1R inhibitor with potential antitumor activity.

Chromeceptin is a novel and potent IGF2 inhibitor,it inhibits the phosphorylation levels of AKT and mTOR.

NVP-AEW541 cis-isomer (also known as AEW541 cis-isomer), the cis-isomer of AEW541 is a novel and potent inhibitor of IGF-1R/InsR with IC50 of 150 nM/140 nM in cell-free assays, it has greater potency and selectivity for IGF-1R in a cell-based assay.

Picropodophyllin (also known as Picropodophyllotoxin, AXL1717 or PPP), a naturally occuring cyclolignan alkaloid isolated from the mayapple plant family, is a novel, potent, orally bioavailable and selective small molecule inhibitor of the IGF-1R with potential antineoplastic activity.

NVP-AEW541 (also known as AEW541; AEW-541) is a novel, potent and selective inhibitor of IGF-1R/InsR with potential antineoplastic activity.

BMS-536924 (also called CS-0117; BMS536924; CS0117) is a novel, potent and ATP-competitive small molecule inhibitor of IGF-1R/IR with potential anticancer activity.

GSK1904529A (also known as GSK-4529; GSK-1904529A; GSK 4529) is a novel, potent and selective inhibitor of IGF-1R (insulin-like growth factor-1 receptor) and IR (insulin receptor) with potential anticancer activity.

AG-1024 (also called Tyrphostin or Tyrphostin AG1024) is a potent and selective inhibitor of IGF-1R (insulin-like growth factor-1) with potential antitumor activity.